E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat.
OBJECTIVE
To determine the role of the endothelial cell adhesion molecules E- and P-selectin in the development and severity of adjuvant-induced arthritis (AIA) in the rat.


METHODS
Lewis rats were immunized subcutaneously with Mycobacterium butyricum (Mb), and blocking monoclonal antibodies (mAb) to rat E- and P-selectin were administered. Clinical score, radiolabeled (51Cr and 111In) blood polymorphonuclear leukocyte (PMN) and monocyte migration to joints, and histologic features were monitored.


RESULTS
When mAb treatment was started on day 5 postimmunization with Mb (preclinical stage), development of AIA was significantly (P < 0.01) inhibited by mAb to E- but not to P-selectin (mean score on day 14 control 10.2, anti-E 2.8, anti-P 9.1). This was associated with markedly decreased migration (by 66-94%) of PMN and monocytes to arthritic joints and diminished cartilage degradation. When treatment was delayed until animals showed signs of arthritis (day 10 postimmunization), only a marginal and variable effect was observed as compared with blockade during the preclinical (day 5) stage. E-selectin blockade on day 5 and day 7 postimmunization resulted in inhibition of antigen-dependent T cell-mediated inflammation, since it decreased T cell migration to sites of dermal-delayed hypersensitivity induced by Mb without affecting migration to concanavalin A or cytokines. The proliferative response of T cells to Mb in vitro was not altered.


CONCLUSIONS
E-selectin plays an important role early in the development of AIA. This adhesion molecule may contribute to the migration of antigen-reactive T cells to peripheral tissues, including the joints where T cells initiate the arthritis.
Issekutz
A C
AC
Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Mu
J Y
JY
Liu
G
G
Melrose
J
J
Berg
E L
EL
D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001169:Arthritis, Experimental / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D002464:Cell Migration Inhibition; D003872:Dermatitis / Q000276:immunology; D019040:E-Selectin / Q000276:immunology*; D007596:Joints / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000276:immunology; D009161:Mycobacterium / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D019007:P-Selectin / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew
D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; D019040:E-Selectin; D019007:P-Selectin